INTERNATIONAL PATENT: ADVERIO PHARMA GMBH FILES APPLICATION FOR "TREATMENT OF CHRONIC HEART FAILURE WITH VERICIGUAT"

GENEVA, March 23 -- ADVERIO PHARMA GMBH (Kaiser-Wilhelm-Allee 151373 Leverkusen) filed a patent application (PCT/EP2025/076150) for "TREATMENT OF CHRONIC HEART FAILURE WITH VERICIGUAT" on Sep 15, 2025. With publication no. WO/2026/057833, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CORDA, Stefano (c/o Bayer Consumer Care AGPeter-Merian-StraBe 844052 Basel), BRATTI, Monica (c/o Bayer AktiengesellschaftKaiser-Wilhelm-Allee 151373 Leverkusen), GUERREIRO GROTE BATALHA, Paula Alexandra (c/o Bayer AktiengesellschaftKaiser-W...